NLRP3 and hyperuricemia: demonstrated that Shizhifang downregulated the gene and protein expression of the NLRP3 inflammasome by modulating the ROS-TXNIP pathway, thereby reducing renal tubule damage and inflammatory response in hyperuricemia rats [141].